Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Goat Polyclonal Anti-HTT Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 85 to 200 aa of human HTT produced in E. coli |
Goat Polyclonal Anti-CD45 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 1,260 aa to the C-terminus of human CD45 produced in E. coli. |
Goat Polyclonal Anti-CD19 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 510 aa to the C-terminus of human CD19 produced in E. coli. |
Goat Polyclonal Anti-Vimentin Antibody
| Applications | FC, IF, WB |
| Reactivities | Human (Expected from sequence similarity: Mouse, Rat, Dog, Pig, Cow) |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for Anti-Vimentin Antibody: Peptide with sequence C-QVINETSQHHDDLE, from the C Terminus of the protein sequence according to NP_003371.2. |
Goat Polyclonal Antibody against DKK1
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence CDHHQASNSSRLHT, from the C Terminus of the protein sequence according to NP_036374. |
Goat Polyclonal Anti-BDNF Antibody
| Applications | IF, IHC |
| Reactivities | Human, Mouse, Rat (Expected from sequence similarity: Dog) |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for Anti-BDNF Antibody: Peptide with sequence ETKCNPMGYTKE, from the internal region of the protein sequence according to NP_001700.2; NP_001700.2; NP_733928.1; NP_733929.1; NP_733930.1; NP_733931.1. |
Goat Polyclonal Anti-Cathepsin D Antibody
| Applications | IF, IHC, WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 275 aa to the C-terminus of human Cathepsin D produced in E. coli. |
Goat Polyclonal Anti-Cathepsin D Antibody
| Applications | IF, IHC, WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 275 aa to the C-terminus of human Cathepsin D produced in E. coli. |
Goat Polyclonal Anti-CD4 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within 50 to 235 aa, corresponding to the external domain of human CD4 produced in E. coli. |
Goat Polyclonal Antibody against ABCC8
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-EFDKPEKLLSRKD, from the C Terminus of the protein sequence according to NP_000343.2. |
Goat Polyclonal Anti-PCNA Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat, Pig (Expected from sequence similarity: Dog, Cow) |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for Anti-PCNA Antibody: Peptide with sequence C-NGNIKLSQTSNVD, from the internal region of the protein sequence according to NP_002583.1. |
Goat Polyclonal Anti-POLDIP2 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat (Expected from sequence similarity: Dog, Cow) |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for Anti-POLDIP2 Antibody: Peptide with sequence KTHTYYQVLIDARDC, from the internal region of the protein sequence according to NP_056399.1. |
Goat Polyclonal Anti-CDH1 (aa662-675) Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat, Pig (Expected from sequence similarity: Dog) |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for Anti-CDH1 (aa662-675) Antibody: Peptide with sequence C-DYKINLKLMDNQNK, from the internal region of the protein sequence according to NP_004351.1. |
Goat Polyclonal Anti-CD31 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 690 aa to the C-terminus of human CD31 produced in E. coli. |
Goat Polyclonal Anti-Rab27 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 120 aa to the C-terminus of mouse Rab27a and rab27b produced in E. coli. |
Goat Polyclonal Antibody against PRPF31
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence KELGNSLDKCKNNEN, from the internal region of the protein sequence according to NP_056444.2. |
Goat Anti-FMR1 (aa116-130) Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-NPNKPATKDTFHKIK, from the internal region of the protein sequence according to NP_002015.1. |
Goat Anti-GRIK3 / GLUR7 Antibody
| Applications | WB |
| Reactivities | Rat, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-KIRQLPIDSDDSRP, from the internal region of the protein sequence according to NP_000822.2. |
Goat Polyclonal Anti-CDH1 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified Recombinant peptide derived from within residues 601 to 701 of human CDH1 produced in E. coli. |
Active filters
Category
- Antibodies
Reactivities
- Rat
Antibody Hosts
- Goat
Families
- Druggable Genome
Filter by
Target Symbol
- CANX (5)
- PDIA3 (5)
- RAB27A (5)
- ATXN3 (4)
- CHM (4)
- GJA1 (4)
- RAB11A (4)
- CDH1 (3)
- RAB5A (3)
- TUBA4A (3)
- ACAT1 (2)
- AIF1 (2)
- AIRE (2)
- ALDH1A1 (2)
- ALDOA (2)
- CACNB4 (2)
- CAT (2)
- CD19 (2)
- CD63 (2)
- CDKN1B (2)
- CLIC1 (2)
- CNR1 (2)
- CTNNB1 (2)
- CTSD (2)
- DOK3 (2)
- FMR1 (2)
- FZD4 (2)
- G6PD (2)
- HMGA1 (2)
- MAOB (2)
- MDH1 (2)
- PON2 (2)
- PTPRC (2)
- RAB14 (2)
- RAN (2)
- RBP4 (2)
- ROR1 (2)
- STAT3 (2)
- STUB1 (2)
- STX6 (2)
- SYNGAP1 (2)
- TBP (2)
- TGM2 (2)
- THBS1 (2)
- TNS1 (2)
- TP53 (2)
- UCP2 (2)
- VDAC2 (2)
- AAK1 (1)
- ABCC1 (1)
- ABCC4 (1)
- ABCC5 (1)
- ABCC8 (1)
- ABCD3 (1)
- ABCD4 (1)
- ABCE1 (1)
- ACHE (1)
- ACO1 (1)
- ACPP (1)
- ACSL4 (1)
- ACTL6B (1)
- ACTN1 (1)
- ACVR1 (1)
- ADAM12 (1)
- ADAM17 (1)
- ADAP1 (1)
- ADH1A (1)
- ADH5 (1)
- ADRA1B (1)
- ADRA2A (1)
- AFM (1)
- AGO1 (1)
- AGTR1 (1)
- AHR (1)
- AIFM1 (1)
- AIMP1 (1)
- AIP (1)
- AKAP3 (1)
- AKAP8 (1)
- AKR1A1 (1)
- AKT2 (1)
- AKT3 (1)
- ALDH18A1 (1)
- ALDH1B1 (1)
- ALDH2 (1)
- ALDH3B1 (1)
- ALDH5A1 (1)
- ALDH6A1 (1)
- ALOX5 (1)
- ALS2 (1)
- ANGPT1 (1)
- ANLN (1)
- ANTXR1 (1)
- ANTXR2 (1)
- ANXA1 (1)
- ANXA2 (1)
- APH1A (1)
- AR (1)
- ARG1 (1)
- ARHGAP26 (1)
Isotypes
Clonalities
Conjugates
Pathways
- Metabolic pathways (60)
- Pathways in cancer (56)
- MAPK signaling pathway (36)
- Neuroactive ligand-receptor interaction (30)
- Wnt signaling pathway (29)
- Focal adhesion (27)
- T cell receptor signaling pathway (25)
- Calcium signaling pathway (24)
- Regulation of actin cytoskeleton (24)
- Huntington's disease (23)
- Prostate cancer (23)
- Endocytosis (22)
- Adherens junction (21)
- Chemokine signaling pathway (20)
- Colorectal cancer (20)
- Neurotrophin signaling pathway (20)
- Endometrial cancer (19)
- Fc gamma R-mediated phagocytosis (19)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (18)
- Adipocytokine signaling pathway (17)
- Cell adhesion molecules (CAMs) (17)
- Natural killer cell mediated cytotoxicity (17)
- ErbB signaling pathway (16)
- Gap junction (16)
- Insulin signaling pathway (16)
- Leukocyte transendothelial migration (16)
- Ubiquitin mediated proteolysis (16)
- Amyotrophic lateral sclerosis (ALS) (15)
- Chronic myeloid leukemia (15)
- Melanogenesis (15)
- Apoptosis (14)
- B cell receptor signaling pathway (14)
- Bladder cancer (14)
- Fc epsilon RI signaling pathway (14)
- Melanoma (14)
- Non-small cell lung cancer (14)
- Renal cell carcinoma (14)
- Tight junction (14)
- Acute myeloid leukemia (13)
- Basal cell carcinoma (13)
- Jak-STAT signaling pathway (13)
- Pathogenic Escherichia coli infection (13)
- Small cell lung cancer (13)
- Thyroid cancer (13)
- Antigen processing and presentation (12)
- Axon guidance (12)
- Glioma (12)
- PPAR signaling pathway (12)
- Pancreatic cancer (12)
- Progesterone-mediated oocyte maturation (12)
- p53 signaling pathway (12)
- Alzheimer's disease (11)
- Arginine and proline metabolism (11)
- Cell cycle (11)
- Cytokine-cytokine receptor interaction (11)
- Dilated cardiomyopathy (11)
- Hypertrophic cardiomyopathy (HCM) (11)
- Oocyte meiosis (11)
- TGF-beta signaling pathway (11)
- Epithelial cell signaling in Helicobacter pylori infection (10)
- Glycolysis / Gluconeogenesis (10)
- Primary immunodeficiency (10)
- Fatty acid metabolism (9)
- Hematopoietic cell lineage (9)
- Pyruvate metabolism (9)
- Tryptophan metabolism (9)
- Type II diabetes mellitus (9)
- VEGF signaling pathway (9)
- mTOR signaling pathway (9)
- Butanoate metabolism (8)
- Lysosome (8)
- Toll-like receptor signaling pathway (8)
- GnRH signaling pathway (7)
- Long-term depression (7)
- Notch signaling pathway (7)
- Parkinson's disease (7)
- SNARE interactions in vesicular transport (7)
- Tyrosine metabolism (7)
- Vascular smooth muscle contraction (7)
- ABC transporters (6)
- Citrate cycle (TCA cycle) (6)
- Drug metabolism - cytochrome P450 (6)
- Hedgehog signaling pathway (6)
- Propanoate metabolism (6)
- Purine metabolism (6)
- Valine (6)
- leucine and isoleucine degradation (6)
- Alanine (5)
- Cardiac muscle contraction (5)
- Glutathione metabolism (5)
- Histidine metabolism (5)
- Lysine degradation (5)
- NOD-like receptor signaling pathway (5)
- Nucleotide excision repair (5)
- Phenylalanine metabolism (5)
- Retinol metabolism (5)
- Viral myocarditis (5)
- aspartate and glutamate metabolism (5)
- Dorso-ventral axis formation (4)
- ECM-receptor interaction (4)
- Glycerolipid metabolism (4)
- Glyoxylate and dicarboxylate metabolism (4)
- Long-term potentiation (4)
- Maturity onset diabetes of the young (4)
- Metabolism of xenobiotics by cytochrome P450 (4)
- Methane metabolism (4)
- Pentose phosphate pathway (4)
- Prion diseases (4)
- RIG-I-like receptor signaling pathway (4)
- Type I diabetes mellitus (4)
- beta-Alanine metabolism (4)
- Arachidonic acid metabolism (3)
- Base excision repair (3)
- Cysteine and methionine metabolism (3)
- Fructose and mannose metabolism (3)
- Glycine (3)
- One carbon pool by folate (3)
- Proteasome (3)
- Synthesis and degradation of ketone bodies (3)
- Systemic lupus erythematosus (3)
- Vibrio cholerae infection (3)
- serine and threonine metabolism (3)
- Allograft rejection (2)
- Ascorbate and aldarate metabolism (2)
- Asthma (2)
- Basal transcription factors (2)
- Circadian rhythm - mammal (2)
- DNA replication (2)
- Inositol phosphate metabolism (2)
- Limonene and pinene degradation (2)
- Mismatch repair (2)
- N-Glycan biosynthesis (2)
- Nitrogen metabolism (2)
- Olfactory transduction (2)
- Oxidative phosphorylation (2)
- Regulation of autophagy (2)
- Renin-angiotensin system (2)
- Riboflavin metabolism (2)
- Ribosome (2)
- Sphingolipid metabolism (2)
- Spliceosome (2)
- Taste transduction (2)
- Taurine and hypotaurine metabolism (2)
- Terpenoid backbone biosynthesis (2)
- Aminoacyl-tRNA biosynthesis (1)
- Androgen and estrogen metabolism (1)
- Autoimmune thyroid disease (1)
- D-Glutamine and D-glutamate metabolism (1)
- Folate biosynthesis (1)
- Glycerophospholipid metabolism (1)
- Graft-versus-host disease (1)
- Nicotinate and nicotinamide metabolism (1)
- O-Glycan biosynthesis (1)
- Pantothenate and CoA biosynthesis (1)
- Phenylalanine (1)
- Phosphatidylinositol signaling system (1)
- Starch and sucrose metabolism (1)
- tyrosine and tryptophan biosynthesis (1)